Key considerations for advancing chimeric antigen receptor (CAR) T-cell therapy for systemic lupus erythematosus (SLE): a multi-partner/disciplinary working group perspective

Early data have shown the potential of chimeric antigen receptor (CAR) T-cell therapies to expand the therapeutic landscape in systemic lupus erythematosus (SLE). While many CAR T-cell therapy learnings can be drawn from the experience of this modality in oncology, key questions remain regarding cli...

Descripció completa

Dades bibliogràfiques

Autors principals:	Ronald F van Vollenhoven, Richard A Furie, James Chung, Paul Brunetta, Georg Schett, Beatrix Bartok, Eric Morand, James B Chung, Vijay Kumar, Naiyer Rizvi, Michel Sadelain, Ronald van Vollenhoven, Sandra Garces, Anca D Askanase, Maximilian F Konig, Franziska Matzkies, Sudhakar Sridharan, Cindy Coney, Mark Peakman, Nikolay Delev, Debra Zack, Nancy Kim, Jennifer C Cooper, Shaun W Jackson, Hoang Nguyen, Jonathan J Hogan, Ann Eldred, Stacie Bell, Elaine Karis, Shaun Jackson, Yupo Ma, Ashley Koegel, Lou Bridges, Aman P Singh, Elena W Y Hsieh, Afsah Amin, Marlene J Carrasco-Alfonso, Katie Groover, Monica Harrington, Gavin H Imperato, Meredith Jackson, Artemio M Jongco, Gary Koretzky, Aimee S Payne, Vaishali Popat, Patricia Rohan, Alexandra Bowden, Susanne Diehl, Thorsten Graef, ElenaW Y Hsieh, Jonathan Hogan, Gavin Imperato, Alisa Koch, Erika Panico, Aimee Payne, Rachel Peterson, Teodora P Staeva, Kerri Wyse
Format:	Artigo
Idioma:	Inglês
Publicat:	BMJ Publishing Group 2025-10-01
Col·lecció:	RMD Open
Accés en línia:	https://rmdopen.bmj.com/content/11/4/e005866.full
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!